Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411883 | SCV000487302 | likely pathogenic | Ataxia-telangiectasia syndrome | 2016-11-11 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV000411883 | SCV003807960 | likely pathogenic | Ataxia-telangiectasia syndrome | 2022-11-18 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PM2 moderated |
Ambry Genetics | RCV004022149 | SCV005017061 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-11-21 | criteria provided, single submitter | clinical testing | The c.4695delT pathogenic mutation, located in coding exon 30 of the ATM gene, results from a deletion of one nucleotide at nucleotide position 4695, causing a translational frameshift with a predicted alternate stop codon (p.P1566Lfs*35). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |